open access
Assessment of quality of life and clinical status in active ankylosing spondylitis patients treated with biologics and physical therapy
Affiliations- Clinical Department of Rheumatology and Connective Tissue Diseases, University Hospital No. 2, Bydgoszcz, Poland
- J. Biziel University Hospital No. 2 in Bydgoszcz, Bydgoszcz, Poland
- Clinical Innovative Therapies, Toruń, Poland
open access
Abstract
Background: According to the current 2009 Assessment in SpondyloArthritis international Society (ASAS) classification criteria, ankylosing spondylitis (AS) is classified as radiographic axial inflammatory spondyloarthropathy. AS is a chronic, progressive inflammatory disease involving primarily the spine and sacroiliac joints, less commonly the peripheral joints, tendinous attachments and internal organs. According to current ASAS and European Alliance of Associations for Rheumatology (EULAR) recommendations, optimal treatment of AS patients needs a combination of pharmacotherapy and non-pharmacological treatment, based on education and rehabilitation treatment. Modern pharmacotherapy for AS, based on anticytokine therapy (biologics), significantly reduces the clinical activity of the disease, reduces active inflammation and inhibits radiographic progression. The aim of this study is to evaluate the effect of physical therapy on functional status, disease activity and quality of life in AS patients treated with biologics.
Material and methods: The study included fifty active AS patients treated with biologics, who were randomly allocated to two groups. Group I patients, in addition to treatment with a tumor necrosis factor alpha (TNF-α) inhibitor, received a course of physical therapy twice with a 6-month interval, which consisted of hydro-air massage and rehabilitation exercises. Group II patients were treated with a TNF-α inhibitor only. In both groups, the study lasted 10 months. At follow-up visits, all participants underwent a physical examination, laboratory tests and the following questionnaire-based studies: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI) and Short Form Health Survey (SF-36) v.2.
Results: The applied physical therapy programme did not improve physical performance in the patients studied. There was no improvement in any of the physical parameters studied. Therefore, the functional status did not improve and disease activity did not decrease in the patients studied. However, some domains from the quality-of-life assessment improved.
Conclusions: Physical therapy and education should be the primary form of non-pharmacological treatment in AS patients treated with biologics.
Abstract
Background: According to the current 2009 Assessment in SpondyloArthritis international Society (ASAS) classification criteria, ankylosing spondylitis (AS) is classified as radiographic axial inflammatory spondyloarthropathy. AS is a chronic, progressive inflammatory disease involving primarily the spine and sacroiliac joints, less commonly the peripheral joints, tendinous attachments and internal organs. According to current ASAS and European Alliance of Associations for Rheumatology (EULAR) recommendations, optimal treatment of AS patients needs a combination of pharmacotherapy and non-pharmacological treatment, based on education and rehabilitation treatment. Modern pharmacotherapy for AS, based on anticytokine therapy (biologics), significantly reduces the clinical activity of the disease, reduces active inflammation and inhibits radiographic progression. The aim of this study is to evaluate the effect of physical therapy on functional status, disease activity and quality of life in AS patients treated with biologics.
Material and methods: The study included fifty active AS patients treated with biologics, who were randomly allocated to two groups. Group I patients, in addition to treatment with a tumor necrosis factor alpha (TNF-α) inhibitor, received a course of physical therapy twice with a 6-month interval, which consisted of hydro-air massage and rehabilitation exercises. Group II patients were treated with a TNF-α inhibitor only. In both groups, the study lasted 10 months. At follow-up visits, all participants underwent a physical examination, laboratory tests and the following questionnaire-based studies: Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Bath Ankylosing Spondylitis Functional Index (BASFI) and Short Form Health Survey (SF-36) v.2.
Results: The applied physical therapy programme did not improve physical performance in the patients studied. There was no improvement in any of the physical parameters studied. Therefore, the functional status did not improve and disease activity did not decrease in the patients studied. However, some domains from the quality-of-life assessment improved.
Conclusions: Physical therapy and education should be the primary form of non-pharmacological treatment in AS patients treated with biologics.
Keywords
ankylosing spondylitis; biological therapies; rehabilitation
About this articleTitle
Assessment of quality of life and clinical status in active ankylosing spondylitis patients treated with biologics and physical therapy
Journal
Issue
Article type
Research paper
Pages
175-181
Published online
2023-11-22
Page views
191
Article views/downloads
135
DOI
Bibliographic record
Rheumatology Forum 2023;9(4):175-181.
Keywords
ankylosing spondylitis
biological therapies
rehabilitation
Authors
Rafał Wojciechowski
Hanna Styczyńska
Daniel Jeka
References (35)- Przepiera-Będzak H, Brzosko M. Seronegatywne zapalenia stawów kręgosłupa. In: Puszczewicz M. ed. Wielka Interna. Reumatologia. Medical Tribune Polska, Warszawa 2016: 281–288.
- Zimmermann-Górska I. Zesztywniające zapalenie stawów kręgosłupa. In: Zimmermann-Górska I. ed. Postępy Reumatologii Klinicznej. Wydawnictwo Lekarskie PZWL, Warszawa 2014: 279–292.
- Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007; 369(9570): 1379–1390.
- Sieper J, Braun J. Ankylosing Spondylitis. Clinican’s manual. Current Medicine Group, London 2009: 5–11.
- Stanisławska-Biernat E, Świerkot J, Tłustochowicz W. Spondyloartropatia osiowa i zesztywniające zapalenie stawów kręgosłupa. Aktualizacja zaleceń postępowania diagnostyczno-terapeutycznego w chorobach reumatycznych na podstawie rekomendacji EULAR/ACR. Reumatologia. 2016; 54(1): 15–21.
- van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984; 27(4): 361–368.
- van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984; 27(4): 361–368.
- Rudwaleit M, Heijde Dv, Landewe R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009; 68(6): 777–783.
- Sieper J, van der Heijde D, Landewé R, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009; 68(6): 784–788.
- van der Heijde D, Ramiro S, Landewé R, et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis. 2011; 70(6): 896–904.
- Beasley J. Osteoarthritis and rheumatoid arthritis: conservative therapeutic management. J Hand Ther. 2012; 25(2): 163–71; quiz 172.
- van der Linden S, van Tubergen A, Hidding A. Physiotherapy in ankylosing spondylitis: what is the evidence? Clin Exp Rheumatol. 2002; 20(6 Suppl 28): S60–S64.
- Biernat-Stanisławska E. Poradnik dla pacjentów. Zesztywniające zapalenie stawów kręgosłupa. UCB/VEDIM, Warszawa 2015.
- Karwat ID, Skwarcz A. Rehabilitacja medyczna — jej cele, założenia i znaczenie praktyczne. Post Nauk Med. 2000; 3: 61–69.
- Mikołajewska E. Fizjoterapia a rehabilitacja medyczna — problemy semantyczne z nazewnictwem w fizjoterapii. Fizjoterapia. 2011; 19(4): 54–64.
- Pacholec A, Księżopolska-Orłowska K, Jędryka-Góral A, et al. Współczesne kierunki rehabilitacji w zapalnych chorobach narządu ruchu. Reumatologia. 2013; 51(4): 298–303.
- Sayfried A. Rehabilitacja osób z chorobami reumatycznymi. In: Milanowska K, Dega W. ed. Rehabilitacja medyczna. Wydawnictwo Lekarskie PZWL, Warszawa 2001: 402–412.
- Passalent LA. Physiotherapy for ankylosing spondylitis: evidence and application. Curr Opin Rheumatol. 2011; 23(2): 142–147.
- Lubrano E, D'Angelo S, Parsons WJ, et al. Effectiveness of rehabilitation in active ankylosing spondylitis assessed by the ASAS response criteria. Rheumatology (Oxford). 2007; 46(11): 1672–1675.
- Strumse YAS, Nordvåg BY, Stanghelle JK, et al. Efficacy of rehabilitation for patients with ankylosing spondylitis: Comparison of a four-week rehabilitation programe in a Mediteranean and a Norwegian setting. J Rehabil Med. 2011; 43(6): 534–542.
- Kjeken I, Bø I, Rønningen A, et al. A three-week multidisciplinary in-patient rehabilitation programme had positive long-term effects in patients with ankylosing spondylitis: randomized controlled trial. J Rehabil Med. 2013; 45(3): 260–267.
- Analay Y, Ozcan E, Karan A, et al. The effectiveness of intensive group exercise on patients with ankylosing spondylitis. Clinical Rehabilitation. 2016; 17(6): 631–636.
- Durmus D, Alayli G, Cil E, et al. Effects of a home-based exercise program on quality of life, fatigue, and depression in patients with ankylosing spondylitis. Rheumatol Int. 2009; 29(6): 673–677.
- Van Tubergen A, Boonen A, Landewé R, et al. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial. Arthritis Rheum. 2002; 47(5): 459–467.
- Dagfinrud H, Kvien TK, Hagen KB. Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev. 2004(4): CD002822.
- Akgul O, Kiliç E, Kiliç G, et al. Physiotherapy and rehabilitation in ankylosing spondylitis: is it still the mainstay of management in the era of biologics? Int J Clin Rheumatol. 2013; 8(5): 579–584.
- Stajszczyk M. Leczenie biologiczne w chorobach reumatycznych w Polsce. Raport. , Warszawa 2013: Raport.
- Bachanek O, Mitura J, Pawlikowski J. Availability and restrictions in the use of biologic therapy in Poland. MONZ. 2015; 21(3): 266–271.
- Colina M, Ciancio G, Govoni M. Rehabilitation treatment strategies in ankylosing spondylitis. J Rheumatol. 2011; 38(10): 2266; author reply 2266.
- Lubrano E, D'Angelo S, Spadaro A, et al. Rehabilitation for ankylosing spondylitis in the era of biologics: any room left for this treatment? J Rheumatol. 2011; 38(7): 1228–1230.
- Ciprian L, Lo Nigro A, Rizzo M, et al. The effects of combined spa therapy and rehabilitation on patients with ankylosing spondylitis being treated with TNF inhibitors. Rheumatol Int. 2013; 33(1): 241–245.
- Masiero S, Bonaldo L, Pigatto M, et al. Rehabilitation treatment in patients with ankylosing spondylitis stabilized with tumor necrosis factor inhibitor therapy: a randomized controlled trial. J Rheumatol. 2011; 38(7): 1335–1342.
- Masiero S, Poli P, Bonaldo L, et al. Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a controlled clinical trial with a 12-month follow-up. Clin Rehabil. 2014; 28(6): 562–572.
- Liang H, Li WR, Zhang H, et al. Concurrent Intervention With Exercises and Stabilized Tumor Necrosis Factor Inhibitor Therapy Reduced the Disease Activity in Patients With Ankylosing Spondylitis: A Meta-Analysis. Medicine (Baltimore). 2015; 94(50): e2254.
- Lubrano E, Spadaro A, Amato G, et al. Tumour necrosis factor alpha inhibitor therapy and rehabilitation for the treatment of ankylosing spondylitis: a systematic review. Semin Arthritis Rheum. 2015; 44(5): 542–550.
